PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

China flag China · Delayed Price · Currency is CNY
40.01
-0.69 (-1.70%)
Apr 29, 2026, 3:04 PM CST
25.90%
Market Cap 9.32B
Revenue (ttm) 2.03B
Net Income (ttm) 196.83M
Shares Out 232.97M
EPS (ttm) 0.91
PE Ratio 44.17
Forward PE 40.01
Dividend 0.28 (0.69%)
Ex-Dividend Date May 30, 2025
Volume 11,431,592
Average Volume 8,724,897
Open 38.12
Previous Close 40.70
Day's Range 38.12 - 40.26
52-Week Range 30.94 - 53.54
Beta 0.65
RSI 59.54
Earnings Date Apr 22, 2026

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small... [Read more]

Sector Healthcare
Founded 2006
Employees 2,400
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300725
Full Company Profile

Financial Performance

In 2025, SHE:300725's revenue was 1.97 billion, an increase of 16.93% compared to the previous year's 1.69 billion. Earnings were 183.74 million, a decrease of -16.31%.

Financial Statements

News

There is no news available yet.